2024 LL&M Highlights
View Video
Available Dates
October 13-16, 2026
Abstracts
Abstracts
Abstracts
Showcase Your Work. Get Published.
Abstracts & Posters
Submit your research to be featured at LL&M Congress 2026. Accepted abstracts will be published in a supplement to the American Journal of Hematology, with awards given for top clinical and translational posters.
Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2026 Lymphoma, Leukemia & Myeloma Congress.
- Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000 attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies.
- Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network.
- Receive Accolades. Each year the Congress Chairs recognize the “Best of” submitted abstracts. Winning abstracts receive free congress registration.
Accepted abstracts will be published in the American Journal of Hematology. Only abstracts received by the submission deadline will be published.
Click here to access the portal.
* Please note that we have modified the abstract submission guidelines. Industry authors can be the lead and/or senior author and can present the research on site.
Abstract Categories
Abstracts will be accepted in the following categories: ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES, or MULTIPLE MYELOMA, or CHRONIC LYMPHOCYTIC LEUKEMIA, and/or LYMPHOMA. Please indicate which category is appropriate by checking the appropriate box in the online submission system.
ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES CATEGORIES
- A1. Clinical Trials, completed
- A2. Procedures and Diagnostics
- A3. Epidemiology and Outcomes Research
- A4. Clinical Case Reports
- A5. Trials in Progress in Leukemia
MULTIPLE MYELOMA CATEGORIES
- M1. Clinical Trials, completed
- M2. Procedures and Diagnostics
- M3. Epidemiology and Outcomes Research
- M4. Clinical Case Reports
- M5. Trials in Progress in Multiple Myeloma
CHRONIC LYMPHOCYTIC LEUKEMIA CATEGORIES
- C1. Clinical Trials, completed
- C2. Procedures and Diagnostics
- C3. Epidemiology and Outcomes Research
- C4. Clinical Case Reports
- C5. Trials in Progress in Chronic Lymphocytic Leukemia
LYMPHOMA CATEGORIES
- L1. Clinical Trials, completed
- L2. Procedures and Diagnostics
- L3. Epidemiology and Outcomes Research
- L4. Clinical Case Reports
- L5. Trials in Progress in Lymphoma
Important Abstract Dates
Abstract Submission Deadline: July 15, 2026, 11:59 PM ET
Abstract Notifications Mailed/Notified: on or before September 10, 2026
Abstract Withdrawal Deadline: September 21, 2026
Abstract Presenter Registration Deadline: October 3, 2026
Poster Information Coming Soon!!!!!!
LL&M Congress does NOT retain the copyright to the abstracts and posters presented at past or future conferences.
We look forward to receiving your exciting work! Please reach out to us at hseymour@hmpglobal.com if you have questions about abstract submission.
Abstracts & Posters
Submit your research to be featured at LL&M Congress 2026. Accepted abstracts will be published in a supplement to the American Journal of Hematology, with awards given for top clinical and translational posters.
Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2026 Lymphoma, Leukemia & Myeloma Congress.
- Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000 attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies.
- Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network.
- Receive Accolades. Each year the Congress Chairs recognize the “Best of” submitted abstracts. Winning abstracts receive free congress registration.
Accepted abstracts will be published in the American Journal of Hematology. Only abstracts received by the submission deadline will be published.
Click here to access the portal.
* Please note that we have modified the abstract submission guidelines. Industry authors can be the lead and/or senior author and can present the research on site.
Abstract Categories
Abstracts will be accepted in the following categories: ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES, or MULTIPLE MYELOMA, or CHRONIC LYMPHOCYTIC LEUKEMIA, and/or LYMPHOMA. Please indicate which category is appropriate by checking the appropriate box in the online submission system.
ACUTE LEUKEMIA & MYELOPROLIFERATIVE / MYELODYSPLASTIC DISEASES CATEGORIES
- A1. Clinical Trials, completed
- A2. Procedures and Diagnostics
- A3. Epidemiology and Outcomes Research
- A4. Clinical Case Reports
- A5. Trials in Progress in Leukemia
MULTIPLE MYELOMA CATEGORIES
- M1. Clinical Trials, completed
- M2. Procedures and Diagnostics
- M3. Epidemiology and Outcomes Research
- M4. Clinical Case Reports
- M5. Trials in Progress in Multiple Myeloma
CHRONIC LYMPHOCYTIC LEUKEMIA CATEGORIES
- C1. Clinical Trials, completed
- C2. Procedures and Diagnostics
- C3. Epidemiology and Outcomes Research
- C4. Clinical Case Reports
- C5. Trials in Progress in Chronic Lymphocytic Leukemia
LYMPHOMA CATEGORIES
- L1. Clinical Trials, completed
- L2. Procedures and Diagnostics
- L3. Epidemiology and Outcomes Research
- L4. Clinical Case Reports
- L5. Trials in Progress in Lymphoma
Important Abstract Dates
Abstract Submission Deadline: July 15, 2026, 11:59 PM ET
Abstract Notifications Mailed/Notified: on or before September 10, 2026
Abstract Withdrawal Deadline: September 21, 2026
Abstract Presenter Registration Deadline: October 3, 2026
Poster Information Coming Soon!!!!!!
LL&M Congress does NOT retain the copyright to the abstracts and posters presented at past or future conferences.
We look forward to receiving your exciting work! Please reach out to us at hseymour@hmpglobal.com if you have questions about abstract submission.
Back to top